243 related articles for article (PubMed ID: 28807954)
1. Acetylsalicylic acid for children with Kawasaki disease.
Sakulchit T; Benseler SM; Goldman RD
Can Fam Physician; 2017 Aug; 63(8):607-609. PubMed ID: 28807954
[No Abstract] [Full Text] [Related]
2. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
3. Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes.
Kim GB; Yu JJ; Yoon KL; Jeong SI; Song YH; Han JW; Hong YM; Joo CU
J Pediatr; 2017 May; 184():125-129.e1. PubMed ID: 28043685
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
Platt B; Belarski E; Manaloor J; Ofner S; Carroll AE; John CC; Wood JB
JAMA Netw Open; 2020 Jan; 3(1):e1918565. PubMed ID: 31899532
[TBL] [Abstract][Full Text] [Related]
5. Aspirin Dose in Kawasaki Disease: The Ongoing Battle.
Dhanrajani A; Chan M; Pau S; Ellsworth J; Petty R; Guzman J
Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1536-1540. PubMed ID: 29287309
[TBL] [Abstract][Full Text] [Related]
6. High-dose aspirin in Kawasaki disease.
Shulman ST
J Pediatr; 1999 Apr; 134(4):523-4. PubMed ID: 10190936
[No Abstract] [Full Text] [Related]
7. Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis.
Zheng X; Yue P; Liu L; Tang C; Ma F; Zhang Y; Wang C; Duan H; Zhou K; Hua Y; Wu G; Li Y
PLoS One; 2019; 14(5):e0217274. PubMed ID: 31117119
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.
Kuo HC; Guo MM; Lo MH; Hsieh KS; Huang YH
BMC Pediatr; 2018 Jun; 18(1):200. PubMed ID: 29933749
[TBL] [Abstract][Full Text] [Related]
9. What dose of aspirin should be used in the initial treatment of Kawasaki disease?
Ho LGY; Curtis N
Arch Dis Child; 2017 Dec; 102(12):1180-1182. PubMed ID: 29066520
[No Abstract] [Full Text] [Related]
10. Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment.
Lee KY; Oh JH; Han JW; Lee JS; Lee BC
Eur J Pediatr; 2005 Jul; 164(7):451-2. PubMed ID: 15782294
[No Abstract] [Full Text] [Related]
11. Do we need high-dose acetylsalicylic acid (ASA) in Kawasaki disease?
Saphyakhajon P; Greene GR
J Pediatr; 1998 Jul; 133(1):167. PubMed ID: 9672536
[No Abstract] [Full Text] [Related]
12. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
[TBL] [Abstract][Full Text] [Related]
13. High-dose aspirin for Kawasaki disease: outdated myth or effective aid?
Amarilyo G; Koren Y; Brik Simon D; Bar-Meir M; Bahat H; Helou MH; Mendelson A; Hezkelo N; Chodick G; Berkun Y; Eisenstein E; Butbul Aviel Y; Barkai G; Bolkier Y; Padeh S; Brik R; Hashkes PJ; Harel L; Uziel Y
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):209-212. PubMed ID: 28079513
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Kawasaki disease with corticosteroid.
Shulman ST; Rowley AH
J Pediatr; 1996 Sep; 129(3):483; author reply 484-5. PubMed ID: 8804349
[No Abstract] [Full Text] [Related]
15. Reye's syndrome developing in an infant on treatment of Kawasaki syndrome.
Wei CM; Chen HL; Lee PI; Chen CM; Ma CY; Hwu WL
J Paediatr Child Health; 2005; 41(5-6):303-4. PubMed ID: 15953335
[TBL] [Abstract][Full Text] [Related]
16. Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease.
Dallaire F; Fortier-Morissette Z; Blais S; Dhanrajani A; Basodan D; Renaud C; Mathew M; De Souza AM; Dionne A; Blanchard J; Saulnier H; Kaspy K; Rached-d'Astous S; Dahdah N; McCrindle BW; Human DG; Scuccimarri R
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562282
[TBL] [Abstract][Full Text] [Related]
17. Revisiting steroids in the primary treatment of acute Kawasaki disease.
Burns JC
J Pediatr; 2006 Sep; 149(3):291-2. PubMed ID: 16939734
[No Abstract] [Full Text] [Related]
18. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease.
Dhanrajani A; Yeung RSM
Curr Opin Rheumatol; 2017 Sep; 29(5):547-552. PubMed ID: 28661936
[TBL] [Abstract][Full Text] [Related]
20. Initial intravenous immunoglobulin therapy without aspirin for acute Kawasaki disease: a retrospective cohort study with a Bayesian inference.
Hayashi K; Miyakoshi C; Hoshino S; Kobayashi N; Nakajima R; Sagawa H; Hayashiya T; Suzuki A; Aota C; Nishijima S; Shimizu Y; Yamakawa M; Tsuda E
BMJ Paediatr Open; 2024 Jan; 8(1):. PubMed ID: 38233084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
